BusinessBioBlast Pharma to Present Final HOPEMD Phase 2 Clinical Study Results of Trehalose in Oculopharyngeal Muscular Dystrophy at the American Academy of Neurology (AAN) 2016 Annual MeetingBy Nasdaq OMXApr 14, 2016, 8:05 PM UTC
